Mark Jason Heath Ellison - 05 Jan 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Signature
/s/ Mark Jason Heath Ellison
Issuer symbol
N/A
Transactions as of
05 Jan 2023
Net transactions value
-$36,481
Form type
4
Filing time
05 Jan 2023, 16:07:25 UTC
Previous filing
29 Jun 2022
Next filing
09 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $36,481 -1,806 -8.3% $20.20 19,830 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.